Updated Dec. 6, 2012 at 6:40 a.m.

Premium Lock GSK doesn't see diabetes drugs winning OK to fight obesity

Published: 2012-12-05 11:22:00
Updated: 2012-12-06 06:40:17

Diabetes Diabetes Image 1 of 2 · Next Image…

A top GlaxoSmithKline executive doesn't believe that GLP-1 diabetes drugs, including its albiglutide experimental compound and Novo Nordisk's Victoza, are unlikely to win clearance to treat obesity because of effectiveness questions....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll